Easy, reliable, high-quality and cost-effective testing for SARS-CoV-2 (COVID-19), in compliance with local regulatory requirements, is crucial to enabling millions of passengers to complete their journeys in comfort and safety. Eurofins has rapidly developed a broad network of around 500 testing centres across Europe and intends to have established around 1000 testing centres by early July.
Eurofins’ network of testing centres covers major travelling hubs and provides testing accessibility in a broad variety of locations such as supermarkets, business parks and residential areas, improving customer proximity and ease of testing.
Eurofins also operates mobile testing centres to further increase availability and access. Such mobile facilities can be used by municipal authorities to reduce pressure on existing testing centres by quickly adding sampling capacity. These mobile collection centres can each process up to 200 PCR tests per day. Eurofins has already launched this service in Belgium, France and Germany.
Additionally, to further support testing, in particular for European travel this summer, Eurofins has created an intuitive web-portal for travelers to book testing appointments and access their testing information, not only in their country of origin, but also at destination locations. All of Eurofins’ testing centres are listed on a single landing page, identifying nearby testing locations. This portal is available in 12 languages; https://www.eurofins.com/covid19-travel-regulations-testing-stations/
Eurofins is committed to offering the best possible testing services to all travellers looking for a seamless, comfortable and safe travel experience. Eurofins has also invested in laboratory capacity and IT solutions that will ensure fast turn-around times for test results (as low as a few hours from receipt of sample at the laboratory for gold standard PCR Tests). Alongside Eurofins’ home-testing offering (where supported by Health Authorities), the Group’s extensive testing centres and mobile sample facilities enable Eurofins to offer an easy and comprehensive experience for international travellers across Europe and the world.
For more information, please visit https://www.eurofins.com/eurofins-safer-work-covid-19-solutions/.
Notes to editor:
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210701005998/en/
Contacts
Javier Sanchez Saura
Investor Relations
Eurofins Scientific SE
E-mail: ir@eurofins.com
